Additionally, OSM stimulation has been shown initiate the activation of the RelB/p50 proteins of the NF-κB pathway both in vitro and in vivo, perpetuating a tumor inflammatory environment in brain cancer cells (183). This evidence concerns the gene NFKB1 and neoplasm.